1975 to 2019 Saw 58 Percent Decrease in Breast Cancer Mortality

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- In the United States, breast cancer screening and treatment were associated with a 58 percent reduction in breast cancer mortality in 2019 compared with 1975, according to a study published in the Jan. 16 issue of the Journal of the American Medical Association.

Jennifer L. Caswell-Jin, M.D., from the Stanford University School of Medicine in California, and colleagues simulated the relative association of breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer with improved mortality using aggregated observational and clinical trial data on the dissemination and effects of screening and treatment.

The researchers found that the age-adjusted breast cancer mortality rate in the United States was 48/100,000 women in 1975 and 27/100,000 women in 2019. The combination of screening, stage I to III treatment, and metastatic treatment was associated with a 58 percent reduction in breast cancer mortality in 2019; 29, 47, and 25 percent of the reduction was associated with treatment of metastatic breast cancer, treatment of stage I to III breast cancer, and mammography screening, respectively. The greatest change in survival after metastatic recurrence occurred between 2000 and 2019 based on simulations, from 1.9 to 3.2 years.

"The results suggest that advances in the treatment of metastatic breast cancer were associated with lower rates of breast cancer mortality in the United States," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-17 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords